ImmuPharma PLCIMM:LSE

49.00
0.00 / 0.00%
60.08k
28.10%
0.1673
Close in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Aug 01 2014 11:06 BST.
IMM:LSE is traded on the London Stock Exchange Alternative Investment Market (Aim)

Summary

On Friday, ImmuPharma PLC (IMM:LSE) closed at 49.00, 30.67% above the 52 week low of 37.50 set on Aug 02, 2013.

52-week range
Today
37.50
Aug 02 2013
78.00
Sep 25 2013
Open49.00
Day high--
Day low--
Bid--
Offer50.00
Previous close49.00
Average volume49.60k
Shares outstanding82.28m
Free float36.25m
P/E (TTM)--
Market cap40.32m GBP
EPS (TTM)-0.0452 GBP
Last IC View
The last IC recommendation on ImmuPharma PLC shares was Hold at 71.00 on 28 Mar 2012
Read the full article
Data delayed at least 15 minutes, as of Aug 01 2014 11:06 BST.

RNS Company announcements

Result of AGM
Access to pioneering research in Bordeaux France
NEW NUCANT PATENTS
Annual Financial Report
Preliminary Results

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
ImmuPharma PLC-1.01%-8.84%-16.60%+28.10%-43.52%
FTSE 100 Index-1.65%-1.82%+2.59%-0.04%+44.94%
GB/HEALTH CARE-0.90%-3.55%+6.98%+9.10%--
GB/PHARMACEUTICALS-1.00%-3.89%+6.31%+8.04%--
Data delayed at least 15 minutes, as of Aug 01 2014 11:06 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.